These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14163645)

  • 21. A study of the urinary coproporphyrin in hepatitis and cirrhosis.
    WATSON CJ
    J Clin Invest; 1946 Nov; 25(6):907. PubMed ID: 20282735
    [No Abstract]   [Full Text] [Related]  

  • 22. Phenylalanine and tyrosine in collagen diseases. Urinary excretion of general intermediary metabolites of tyrosine in patients with collagen disease and liver disease.
    NISHIMURA N; MAEDA K; YASUI M; OKAMOTO H; MATSUNAKA M; TOSHINA H
    Arch Dermatol; 1961 Apr; 83():644-52. PubMed ID: 13729226
    [No Abstract]   [Full Text] [Related]  

  • 23. AMINO ACID METABOLISM IN KWASHIORKOR. II. METABOLISM OF PHENYLALANINE AND TYROSINE.
    WHITEHEAD RG; MILBURN TR
    Clin Sci; 1964 Apr; 26():279-89. PubMed ID: 14161060
    [No Abstract]   [Full Text] [Related]  

  • 24. [THE AZOSULFAMIDE TEST AS A LIVER FUNCTION TEST].
    MEONI S; BRUCOLI V; BIAGI G
    Fegato; 1963 Dec; 18():421-31. PubMed ID: 14117141
    [No Abstract]   [Full Text] [Related]  

  • 25. Tyrosinosis: a patient without liver or renal disease.
    Holston JL; Levy HL; Tomlin GA; Atkins RJ; Patton TH; Hosty TS
    Pediatrics; 1971 Sep; 48(3):393-400. PubMed ID: 5094340
    [No Abstract]   [Full Text] [Related]  

  • 26. [Urinary aldosterone excretion in epidemic hepatitis and in liver cirrhosis].
    WOLFF HP; KOCZOREK KR
    Klin Wochenschr; 1955 Dec; 33(45-46):1104-5. PubMed ID: 13287023
    [No Abstract]   [Full Text] [Related]  

  • 27. [CLINICAL RESEARCH ON PYRUVIC ACID METABOLISM IN LIVER DISEASES. II. EFFECTS OF DIFFERENT DRUGS ON THE PYRUVIC ACID BLOOD LEVEL IN LIVER DISEASES].
    KONO H
    Acta Med Okayama (1952); 1964 Apr; 18():93-110. PubMed ID: 14204463
    [No Abstract]   [Full Text] [Related]  

  • 28. Tyrosinosis. A study of 6 cases.
    Halvorsen S; Pande H; Loken AC; Gjessing LR
    Arch Dis Child; 1966 Jun; 41(217):238-49. PubMed ID: 5940613
    [No Abstract]   [Full Text] [Related]  

  • 29. [THE LATEX DROP TEST IN LIVER DISEASES].
    WEINREICH J; KUEHN HA
    Acta Hepatosplenol; 1965; 12():44-50. PubMed ID: 14271716
    [No Abstract]   [Full Text] [Related]  

  • 30. [IDENTIFICATION AND DETERMINATION OF P-HYDROXYPHENYLPYRUVIC ACID AND ITS DERIVATIVES IN URINE].
    HUMBEL R
    Med Lab (Stuttg); 1964 Mar; 17():68-71. PubMed ID: 14193284
    [No Abstract]   [Full Text] [Related]  

  • 31. Tyrosine metabolism in patients with liver disease.
    Levine RJ; Conn HO
    J Clin Invest; 1967 Dec; 46(12):2012-20. PubMed ID: 6074004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [THE DIURNAL VARIATION OF CORTISOL AND CORTICOSTERONE METABOLITES IN HEALTHY SUBJECTS AND IN LIVER DISEASE PATIENTS].
    STANCAKOVA A
    Endokrinologie; 1963 Feb; 44():49-62. PubMed ID: 14065123
    [No Abstract]   [Full Text] [Related]  

  • 33. [CASE CONTRIBUTION TO THE CLINICAL VALUE OF A NEW SERUM FLOCCULATION TEST: THE COPPER ACETATE TEST].
    PITTERA A; CASSIA B; FERLITO S
    Med Clin Sper; 1964; 14():71-94. PubMed ID: 14182757
    [No Abstract]   [Full Text] [Related]  

  • 34. EFFECT OF PROTEIN ADMINISTRATION ON AMMONIA LEVELS OF PATIENTS WITH LIVER DISEASE.
    NIELSEN OF; LIANG YK; CHEY WY
    Am J Med Sci; 1965 Aug; 250():121-30. PubMed ID: 14331941
    [No Abstract]   [Full Text] [Related]  

  • 35. [THE VALUE OF FRACTIONAL CLEARANCE OF BSP IN THE DIAGNOSIS OF CHRONIC HEPATOPATHIES].
    NICOLAESCU T; FELBERG B; RUSOVICI L
    Med Interna (Bucur); 1964 Aug; 16():959-67. PubMed ID: 14192603
    [No Abstract]   [Full Text] [Related]  

  • 36. [CONSIDERATIONS ON SOME BLOOD COAGULATION TESTS AS LIVER FUNCTION TESTS WITH SPECIAL REFERENCE TO OWREN'S THROMBOTEST].
    PUGLIESE F; SILVESTRI G
    Policlinico Med; 1964 Apr; 71():140-8. PubMed ID: 14146284
    [No Abstract]   [Full Text] [Related]  

  • 37. FOLATE DEFICIENCY IN CHRONIC LIVER DISEASE.
    KLIPSTEIN FA; LINDENBAUM J
    Blood; 1965 Apr; 25():443-56. PubMed ID: 14284334
    [No Abstract]   [Full Text] [Related]  

  • 38. [TYROSINE METABOLISM DISORDERS IN PATIENTS WITH COLLAGEN DISEASES. II. 2,5-DIHYDROXYPHENYLPYRUVIC ACID AND ITS CLINICAL SIGNIFICANCE IN COLLAGEN DISEASES].
    KVIATKOVSKAIA AN; KAINOVA AS; MIKHAILOVA IN
    Ter Arkh; 1964 Oct; 36():76-81. PubMed ID: 14309922
    [No Abstract]   [Full Text] [Related]  

  • 39. [CLINICAL TRIAL OF POTASSIUM AND MAGNESIUM SALTS OF ASPARTIC ACID IN LIVER DISEASES].
    KATSU M; OGAWA J; NAKAGAWA H; OSAKO R; ABE T; YAMAMOTO I
    Chiryo; 1964; 46():959-66. PubMed ID: 14144023
    [No Abstract]   [Full Text] [Related]  

  • 40. [CLINICAL EXPERIENCES WITH A SIMPLE PROGRAM FOR LABORATORY TESTS IN THE DIFFERENTIAL DIAGNOSIS OF LIVER DISEASES].
    TEICHMANN W
    Z Gesamte Inn Med; 1964 Sep; 19():714-8. PubMed ID: 14236506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.